News – Page 824 – Endpoints News

Novartis quietly buries another failed eczema drug, with a $485M hit embedded in the footnotes

5 years ago

Chris Garabedian's incubator leads Series A funding for gene therapy manufacturer/developer combo

5 years ago

Roche partners on a slate of Jnana's immunology, neurology targets, rewarding its faith in the SLC transporter class

5 years ago

Acadia’s shot at beating a ‘fickle’ major depression challenge misses the mark in a failed PhIII

5 years ago

Not just AstraZeneca — CanSino Biologics also unveils Phase II data, showing antibody and T cell response

5 years ago

AstraZeneca, Oxford researchers champion a one-two punch against Covid-19 in first human study

5 years ago

Amplyx touts upbeat readout from a small PhII study for lead antifungal

5 years ago

Small AI biotech BioXcel surges on positive PhIII results, setting up dementia and Alzheimer’s test

5 years ago

Ex-Sanofi Genzyme chief David Meeker hops to a new biotech CEO post, this time focusing on quick leap to ...

5 years ago

BeiGene expands pipeline and hops on board a quest to cure hep B, inking a $540M deal with a fellow upstart biotech

5 years ago

Sanofi continuing with API spinoff despite French on-shoring push, tensions with union — Reuters

5 years ago

Art Krieg’s Checkmate executes a snappy 1-2 biotech gambit — big crossover followed by an instant IPO

5 years ago

Covid-19 roundup: Fauci pushes back on Merck’s Frazier; Pfizer unveils first vaccine supply deal as UK nabs 90M ...

5 years ago

GSK injects $293M cash into CureVac, forging a deal to develop new mRNA vaccines and antibodies

5 years ago

UK biotech rockets up on Covid-19 'breakthrough' for inhaled interferon beta — can its small study live up to the ...

5 years ago

J&J-partnered MeiraGTx aims at Biogen with new eye gene therapy data

5 years ago

BMS gets the ball rolling on liso-cel in Europe; BeiGene files China NDA for in-house PARP drug

5 years ago

China's CRO powerhouse Tigermed to seek $1B IPO in Hong Kong — report

5 years ago

A Jennifer Doudna-led team finds a new CRISPR enzyme in the giant viruses of a California mud bog

5 years ago

In anticipation of PhIII trial results, Amicus pares down old debt with $400 million loan

5 years ago

Eli Lilly’s mirikizumab joins the club beating up on Cosentyx as another head-to-head study leaves Novartis’ drug ...

5 years ago

Tony Kingsley takes over the reins at Scholar Rock; Idorsia taps pharma vet Patricia Torr for new US ops

5 years ago

Covid-19 roundup: EU looks to pre-order vaccines from Moderna, Sanofi, J&J, BioNTech, CureVac — report

5 years ago

Three more biotechs tumble onto Wall Street today, raising $475M as the IPO party rocks on

5 years ago

First page Previous page 821 822 823824825 826 827 Next page Last page